Advertisements


We are Sorry, This Page doesn't Exist


Mid-Day Market Update: Dow Down Over 150 Points; CASI Pharmaceuticals Shares Spike Higher

Midway through trading Thursday, the Dow traded down 0.65 percent to 24,498.55 while the NASDAQ declined 0.51 percent to 7,741.89. The S&P also fell, dropping 0.49 percent to 2,753.90. read more.....»»

Category: blogSource: benzinga15 hr. 4 min. ago

Valeant Down as FDA Refuses to Approve Duobrii For Psoriasis

Valeant (VRX) suffers a setback as the FDA issues a CRL for its plaque psoriasis lotion, Duobrii. Shares of Valeant Pharmaceuticals International, In.....»»

Category: personnelSource: nytJun 19th, 2018

Valeant Pharmaceuticals Intl Inc Shares Sink on Psoriasis Treatment Rejection by FDA

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valean.....»»

Category: topSource: investorplaceJun 19th, 2018

Why AMD’s Stock Price Is Soaring and Intel’s Is Falling Hard

Investors discern a tipping point is near. Shares of surging chipmaker Advanced Micro Devices jumped another 6% at midday on M.....»»

Category: europeSource: fortuneJun 18th, 2018

Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion

Valeant Pharmaceuticals International Inc. shares dropped 5.4% in premarket trade on Mond.....»»

Category: topSource: marketwatchJun 18th, 2018

Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion

Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion intended to treat plaque psoriasis......»»

Category: blogSource: 247wallstJun 18th, 2018

Kitov Pharmaceuticals agrees to acquire all minority shares of TyrNovo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Mid-Afternoon Market Update: Sonoma Pharmaceuticals Falls Following Q4 Miss; Teligent Shares Surge

Toward the end of trading Thursday, the Dow traded down 0.07 percent to 25,182.65 while the NASDAQ climbed 0.77 percent to 7,754.77. The S&P also rose, gaining 0.24 percent to 2,782.25. read more.....»»

Category: blogSource: benzingaJun 14th, 2018

Idera Stock Down, Study on Dermatomyositis Candidate Fails

Shares of Idera (IDRA) decline following the failure of a phase II study of its pipeline candidate, IMO-8400, on adult patients with dermatomyositis. Idera Pharmaceuticals Inc IDRA announced that the phase II clinical study, eva.....»»

Category: smallbizSource: nytJun 13th, 2018

Here"s Why Netflix (NFLX) Stock Is Surging Today

Shares of Netflix (NFLX) moved nearly 2.5% higher in early morning trading Wednesday after the video streaming behemoth received its most bullish analyst call to date. Shares of N.....»»

Category: smallbizSource: nytJun 13th, 2018

Madrigal Pharmaceuticals Inc (MDGL) CEO Paul A Friedman Sold $21.1 million of Shares

Related Stocks: MDGL,.....»»

Category: blogSource: gurufocusJun 12th, 2018

Mid-Afternoon Market Update: Enzo Biochem Falls After Q3 Results; Galmed Pharmaceuticals Shares Surge

Toward the end of trading Tuesday, the Dow traded down 0.02 percent to 25,316.10 while the NASDAQ climbed 0.55 percent to 7,702.42. The S&P also rose, gaining 0.16 percent to 2,786.42. read more.....»»

Category: blogSource: benzingaJun 12th, 2018

Snap stock gains after analyst highlights stock loan recall, surging borrow rates

Shares of Snap Inc. are up 5.6% in Tuesday trading after a report from S3 Partners highlighted "an avalanche of stock loan recalls" that hit during Monday's session and suggested that borrowing rates could increase due to limited s.....»»

Category: topSource: marketwatchJun 12th, 2018

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares......»»

Category: blogSource: 247wallstJun 12th, 2018

Galmed Pharmaceuticals" stock rockets 161% after trial results support FDA marketing application

Shares of Galmed Pharmaceuticals Ltd. nearly tripled in very active premarket trade Tuesday, after the Israel-based biopharmaceutical compan.....»»

Category: topSource: marketwatchJun 12th, 2018

Intercept Pharmaceuticals: Buyout Speculation Stokes Shares

Intercept Pharmaceuticals: Buyout Speculation Stokes Shares.....»»

Category: topSource: seekingalphaJun 12th, 2018

Aerie Pharmaceuticals Inc (AERI) CEO Vicente Jr Anido Sold $9.3 million of Shares

Related Stocks: AERI,.....»»

Category: blogSource: gurufocusJun 8th, 2018

Aurinia Pharmaceuticals (AUPH) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsJun 7th, 2018

Madrigal Pharmaceuticals to sell $200M of stock, insiders to offer 364K shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Verrica Pharmaceuticals Closes in on IPO

Verrica Pharmaceuticals expects to price 5 million shares in the range that results in an initial public offering valued up to $92 million......»»

Category: blogSource: 247wallstJun 5th, 2018